Steven Shak, Genomic Health, Inc. (IMAGE)

ECOG-ACRIN Cancer Research Group

Steven Shak, Genomic Health, Inc.

Caption

Dr. Shak is chief scientific officer at Genomic Health, Inc., the company researching and developing the Oncotype DX(R) Recurrence Score(r), which is a 21-gene test to predict the risk of recurrence in woman diagnosed with early-stage breast cancer.

Credit

Steven Shak

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.